Wang, H.; Luo, Y.; Ran, R.; Li, X.; Ling, H.; Wen, F.; Yu, T.
IDO1 Modulates the Sensitivity of Epithelial Ovarian Cancer Cells to Cisplatin through ROS/p53-Dependent Apoptosis. Int. J. Mol. Sci. 2022, 23, 12002.
https://doi.org/10.3390/ijms231912002
AMA Style
Wang H, Luo Y, Ran R, Li X, Ling H, Wen F, Yu T.
IDO1 Modulates the Sensitivity of Epithelial Ovarian Cancer Cells to Cisplatin through ROS/p53-Dependent Apoptosis. International Journal of Molecular Sciences. 2022; 23(19):12002.
https://doi.org/10.3390/ijms231912002
Chicago/Turabian Style
Wang, Houmei, Yuanyuan Luo, Rui Ran, Xinya Li, Hongjian Ling, Fang Wen, and Tinghe Yu.
2022. "IDO1 Modulates the Sensitivity of Epithelial Ovarian Cancer Cells to Cisplatin through ROS/p53-Dependent Apoptosis" International Journal of Molecular Sciences 23, no. 19: 12002.
https://doi.org/10.3390/ijms231912002
APA Style
Wang, H., Luo, Y., Ran, R., Li, X., Ling, H., Wen, F., & Yu, T.
(2022). IDO1 Modulates the Sensitivity of Epithelial Ovarian Cancer Cells to Cisplatin through ROS/p53-Dependent Apoptosis. International Journal of Molecular Sciences, 23(19), 12002.
https://doi.org/10.3390/ijms231912002